FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119463521> ?p ?o ?g. }

• W3119463521 endingPage "1267" @default.
• W3119463521 startingPage "1259" @default.
• W3119463521 abstract "To evaluate the efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with active ankylosing spondylitis (AS).This phase III, multicenter, double-blind, placebo-controlled study (ClinicalTrials.gov: NCT01583374) randomized patients with active AS (1:1:1) to placebo, apremilast 20 mg twice daily, or apremilast 30 mg twice daily for 24 weeks, followed by a long-term extension phase (up to 5 yrs). The primary endpoint was Assessment of the Spondyloarthritis international Society 20 (ASAS20) response at Week 16. The effect of treatment on radiographic outcomes after 104 weeks was assessed using the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS).In total, 490 patients with active AS were randomized in the study (placebo: n = 164; apremilast 20 mg twice daily: n = 163; apremilast 30 mg twice daily: n = 163). The primary endpoint of ASAS20 response at Week 16 was not met (placebo: 37%; apremilast 20 mg twice daily: 35%; apremilast 30 mg twice daily: 33%; P = 0.44 vs placebo). At Week 104, mean (SD) changes from baseline in mSASSS were 0.83 (3.6), 0.98 (2.2), and 0.57 (1.9) in patients initially randomized to placebo, apremilast 20 mg twice daily, and apremilast 30 mg twice daily, respectively. The most frequently reported adverse events through Week 104 were diarrhea, nasopharyngitis, upper respiratory infection, and nausea.No clinical benefit was observed with apremilast treatment in patients with active AS. The safety and tolerability of apremilast were consistent with its known profile." @default.
• W3119463521 created "2021-01-18" @default.
• W3119463521 creator A5000282057 @default.
• W3119463521 creator A5026433456 @default.
• W3119463521 creator A5041749765 @default.
• W3119463521 creator A5062487589 @default.
• W3119463521 creator A5082393421 @default.
• W3119463521 creator A5089158758 @default.
• W3119463521 date "2021-02-15" @default.
• W3119463521 modified "2023-10-17" @default.
• W3119463521 title "A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis" @default.
• W3119463521 cites W1604295258 @default.
• W3119463521 cites W1919283206 @default.
• W3119463521 cites W1965589159 @default.
• W3119463521 cites W1966756689 @default.
• W3119463521 cites W2012643422 @default.
• W3119463521 cites W2058968313 @default.
• W3119463521 cites W2092734189 @default.
• W3119463521 cites W2096092199 @default.
• W3119463521 cites W2097209079 @default.
• W3119463521 cites W2103874459 @default.
• W3119463521 cites W2110917772 @default.
• W3119463521 cites W2118596556 @default.
• W3119463521 cites W2119067278 @default.
• W3119463521 cites W2124551692 @default.
• W3119463521 cites W2131082989 @default.
• W3119463521 cites W2131727392 @default.
• W3119463521 cites W2143071958 @default.
• W3119463521 cites W2171675095 @default.
• W3119463521 cites W2266045195 @default.
• W3119463521 cites W2403627882 @default.
• W3119463521 cites W2471133371 @default.
• W3119463521 cites W2474510828 @default.
• W3119463521 cites W2572897530 @default.
• W3119463521 cites W2795686103 @default.
• W3119463521 doi "https://doi.org/10.3899/jrheum.201088" @default.
• W3119463521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33589554" @default.
• W3119463521 hasPublicationYear "2021" @default.
• W3119463521 type Work @default.
• W3119463521 sameAs 3119463521 @default.
• W3119463521 citedByCount "7" @default.
• W3119463521 countsByYear W31194635212022 @default.
• W3119463521 countsByYear W31194635212023 @default.
• W3119463521 crossrefType "journal-article" @default.
• W3119463521 hasAuthorship W3119463521A5000282057 @default.
• W3119463521 hasAuthorship W3119463521A5026433456 @default.
• W3119463521 hasAuthorship W3119463521A5041749765 @default.
• W3119463521 hasAuthorship W3119463521A5062487589 @default.
• W3119463521 hasAuthorship W3119463521A5082393421 @default.
• W3119463521 hasAuthorship W3119463521A5089158758 @default.
• W3119463521 hasBestOaLocation W31194635212 @default.
• W3119463521 hasConcept C126322002 @default.
• W3119463521 hasConcept C142724271 @default.
• W3119463521 hasConcept C168563851 @default.
• W3119463521 hasConcept C197934379 @default.
• W3119463521 hasConcept C203092338 @default.
• W3119463521 hasConcept C204787440 @default.
• W3119463521 hasConcept C27081682 @default.
• W3119463521 hasConcept C2776260265 @default.
• W3119463521 hasConcept C2777077863 @default.
• W3119463521 hasConcept C2777402515 @default.
• W3119463521 hasConcept C2778375690 @default.
• W3119463521 hasConcept C2781427535 @default.
• W3119463521 hasConcept C71924100 @default.
• W3119463521 hasConcept C90924648 @default.
• W3119463521 hasConceptScore W3119463521C126322002 @default.
• W3119463521 hasConceptScore W3119463521C142724271 @default.
• W3119463521 hasConceptScore W3119463521C168563851 @default.
• W3119463521 hasConceptScore W3119463521C197934379 @default.
• W3119463521 hasConceptScore W3119463521C203092338 @default.
• W3119463521 hasConceptScore W3119463521C204787440 @default.
• W3119463521 hasConceptScore W3119463521C27081682 @default.
• W3119463521 hasConceptScore W3119463521C2776260265 @default.
• W3119463521 hasConceptScore W3119463521C2777077863 @default.
• W3119463521 hasConceptScore W3119463521C2777402515 @default.
• W3119463521 hasConceptScore W3119463521C2778375690 @default.
• W3119463521 hasConceptScore W3119463521C2781427535 @default.
• W3119463521 hasConceptScore W3119463521C71924100 @default.
• W3119463521 hasConceptScore W3119463521C90924648 @default.
• W3119463521 hasIssue "8" @default.
• W3119463521 hasLocation W31194635211 @default.
• W3119463521 hasLocation W31194635212 @default.
• W3119463521 hasLocation W31194635213 @default.
• W3119463521 hasOpenAccess W3119463521 @default.
• W3119463521 hasPrimaryLocation W31194635211 @default.
• W3119463521 hasRelatedWork W1966047811 @default.
• W3119463521 hasRelatedWork W2003042623 @default.
• W3119463521 hasRelatedWork W2006519956 @default.
• W3119463521 hasRelatedWork W202460821 @default.
• W3119463521 hasRelatedWork W2030348591 @default.
• W3119463521 hasRelatedWork W3119463521 @default.
• W3119463521 hasRelatedWork W3130793960 @default.
• W3119463521 hasRelatedWork W3176947508 @default.
• W3119463521 hasRelatedWork W3212096909 @default.
• W3119463521 hasRelatedWork W4224437443 @default.
• W3119463521 hasVolume "48" @default.
• W3119463521 isParatext "false" @default.
• W3119463521 isRetracted "false" @default.

• next